Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FUQBQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,019
Award facts
- Contract value 100% obligated
- $12,019.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,019.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials. The contract was competitively awarded without set-aside provisions and carries an ultimate completion date of September 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Ocrevus (ocrelizumab) is a specialty pharmaceutical product used in the treatment of multiple sclerosis, representing the type of critical medical commodity that DLA procures to support Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen's role as a pharmaceutical prime vendor demonstrates its strategic importance to federal medical supply chains, with the company maintaining capability to fulfill specialized pharmaceutical requirements across multiple therapeutic domains on a competitive basis.
Quick answers
Who was awarded contract SPE2DB25FUQBQ?
SPE2DB25FUQBQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FUQBQ worth?
The government has obligated $12,019 on SPE2DB25FUQBQ.
Is contract SPE2DB25FUQBQ an order under another contract?
Yes. SPE2DB25FUQBQ is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUQBQ competed?
The extent of competition for SPE2DB25FUQBQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award